Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

After pathology and CT review ... viewarticle/408749 Endoscopic view of left nasal cavity showing polyposis in middle meatus. Notice how the polyps exhibit a glistening, almost translucent ...

GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and ...

In this paper we will describe the possible connection between nasal polyposis and allergy, based on an analysis of (1) the occurrence of polyps and of allergy, (2) the anatomy and histology of nasal ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

Opens in a new tab or window The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps to include adolescents as well ...

Small nasal polyps can be harmless, but if a nasal polyp blocks the sinuses or airway, it can lead to infections, difficulty ...

Nasal polyps are benign (non-cancerous) growths that develop inside the nose or sinuses. Common causes of nasal polyps include asthma, allergies, and chronic sinus infections. Nasal polyps are ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

Nasal corticosteroid sprays can also help treat allergic rhinitis and noncancerous nasal polyps (tissue growths) in the lining of your nasal passage. You can typically use this type of nasal spray ...